Natural beta interferon in acute type-C hepatitis patients: A randomized controlled trial

Italian Journal of Gastroenterology and Hepatology

Volumn 30, Issue 2, 1998, Pages 181-184

  Calleri, G ^a   Colombatto, P ^a   Gozzelino, M ^a   Chieppa, F ^a   Romano, P ^a   Delmastro, B ^a   Macor, A ^a   Cariti, G ^a   Brunetto, M R ^a   Grillone, W ^a   Bonino, F ^a  

^a AMEDEO DI SAVOIA HOSPITAL   (Italy)

Author keywords

Hepatitis C viruses; Interferon beta

Indexed keywords

ANTIVIRUS AGENT; BETA INTERFERON; VIRUS RNA;

ARTICLE; CHRONICITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HEPATITIS C; HUMAN; INFLUENZA; INTRAMUSCULAR DRUG ADMINISTRATION; ITALY; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL;

EID: 7344231046     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Dienstag JL. Non-A, Non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterology 1983;85:439-62.
2. Poynard T, Leroy V, Cohard M, Thevenot T, Mathurin P, Opolon P, et al. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose on duration. Hepatology 1996;24:778-89.
3. Lampertico P, Rumi M, Romeo R, Craxi A, Soffredini R, Biassoni D, et al. A multicenter randomized controlled trial of recombinant interferon A-2b in patients with acute transfusion-associated hepatitis C. Hepatology 1994;19:19-22.
4. Viladomiu L, Genesca J, Esteban JI, Allende H, Gonzalez A, Lopez-Talavera JC, et al. Interferon-alpha in acute posttransfusion hepatitis C: a randomized, controlled trial. Hepatology 1992;15:767-9.
5. Tassopoulos NC, Koutelou MG, Papatheodoridis G, Polychronaky H, Delladetsima I, Giannikakis T, et al. Recombinant human interferon alfa-2b treatment for acute non-A, non-B hepatitis. Gut 1993;(Suppl.):S130-2.
6. Omata M, Yokosuka O, Takano S, Kato N, Osoda K, Imazeki F, et al. Resolution of acute hepatitis C after therapy with natural beta interferon. Lancet 1991;338:914-5.
7. Ohnishi K, Nomura F, Nakano M. Interferon therapy for acute post-transfusion non-A, non-B hepatitis: response with respect to anti-hepatitis C virus antibody status. Am J Gastroenterol 1991;86:1041-8.
8. Cammà C, Almasio P, Craxî A. Interferon as treatment for acute hepatitis C: a meta-analysis. Dig Dis Sei 1996;41:1248-55.
9. Takano S, Satomura Y, Omata M, Japan Acute Hepatitis Cooperative Study Group. Effect of interferon beta on non-A, non-B acute hepatitis: a prospective, randomized, controlled-dose study. Gastroenterology 1994;107:805-11.
10. Capalbo M, Actis R, Brunetto MR, Poli G, Baldi M, Palmisano L, et al. Treatment of chronic hepatitis B with beta interferon given intramuscularly: a pilot study. Ital J Gastroenterol 1992;24:203-5.
11. Villa E, Trande P, Grottola A, Buttafoco P, Rebecchi AM, Stroffolini T, et al. Alpha but not beta interferon is useful in chronic active hepatitis due to hepatitis C virus. A prospective, doubleblind, randomized study. Dig Dis Sei 1996;41:1241-7.
12. Saracco G, Ghisetti V, Rocca G, Roffi, Cariti G, Calleri G, et al. Different prevalence of HCV genotypes in relation to clinical and virological parameters in a non cirrhotic population. Hepatology 1997;26:212A.